Falkman L, Sundin A, Skogseid B, Botling J, Bernardo Y, Wallin G, et al. Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors. ujms [Internet]. 2024 Apr. 9 [cited 2026 Nov. 14];129(S1):e10660. Available from: https://ujms.net/index.php/ujms/article/view/10660